Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China

Objectives: Hepatitis E virus (HEV) is a single-stranded RNA virus infecting a variety of animals and humans. Little is known of HEV infection among cancer patients in China. This study provides new epidemiological data for the prevalence of HEV co-infection in cancer patients, indicating that HEV i...

Full description

Bibliographic Details
Main Authors: Meng-Jie Bai, Na Zhou, Wei Dong, Guang-Xing Li, Wei Cong, Xing-Quan Zhu
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971218300869
id doaj-5b93bd62925b4fe89c7bb56f63fd2a25
record_format Article
spelling doaj-5b93bd62925b4fe89c7bb56f63fd2a252020-11-24T21:56:50ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112018-06-0171C424710.1016/j.ijid.2018.04.003Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern ChinaMeng-Jie Bai0Na Zhou1Wei Dong2Guang-Xing Li3Wei Cong4Xing-Quan Zhu5State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaAffiliated Hospital of Qingdao University, Qingdao, Shandong Province, PR ChinaWeihaiwei People’s Hospital, Weihai, Shandong Province, PR ChinaState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaObjectives: Hepatitis E virus (HEV) is a single-stranded RNA virus infecting a variety of animals and humans. Little is known of HEV infection among cancer patients in China. This study provides new epidemiological data for the prevalence of HEV co-infection in cancer patients, indicating that HEV infection is common in this group. Methods: A total of 950 cancer patients and 950 control volunteers from Shandong Province, eastern China, were recruited to participate in this investigation. Blood samples from patients and controls were examined for anti-HEV IgG and IgM antibodies using ELISAs. Results: The overall seroprevalence of IgG and IgM antibodies to HEV was significantly higher in cancer patients (247/950, 26.0%) than in controls (123/950, 13.0%) (p < 0.001). In cancer patients, 22.7% of serum samples were anti-HEV IgG-positive, and in control subjects, 11.0% were anti-HEV IgG-positive (p < 0.001). For IgM antibodies, seroprevalence was 4.2% in cancer patients (n = 40) and 2.1% in controls (n = 20) (p = 0.009). The seroprevalence of HEV was higher in cancer patients who had dogs in their home (31.7%) when compared to other cancer patients. The highest seroprevalence of HEV infection was found in leukemia patients (32.3%), followed by liver cancer patients (31.1%); the lowest HEV seroprevalence was detected in patients with gastric cancer (18.9%). Conclusions: This investigation revealed that the seroprevalence of HEV was significantly higher in cancer patients than in controls in eastern China. Therefore, cancer patients are a high-risk population and should be kept away from sources of HEV infection.http://www.sciencedirect.com/science/article/pii/S1201971218300869Hepatitis E virusCancer patientsSeroprevalenceRisk factorsChina
collection DOAJ
language English
format Article
sources DOAJ
author Meng-Jie Bai
Na Zhou
Wei Dong
Guang-Xing Li
Wei Cong
Xing-Quan Zhu
spellingShingle Meng-Jie Bai
Na Zhou
Wei Dong
Guang-Xing Li
Wei Cong
Xing-Quan Zhu
Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China
International Journal of Infectious Diseases
Hepatitis E virus
Cancer patients
Seroprevalence
Risk factors
China
author_facet Meng-Jie Bai
Na Zhou
Wei Dong
Guang-Xing Li
Wei Cong
Xing-Quan Zhu
author_sort Meng-Jie Bai
title Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China
title_short Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China
title_full Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China
title_fullStr Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China
title_full_unstemmed Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China
title_sort seroprevalence and risk factors of hepatitis e virus infection in cancer patients in eastern china
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
1878-3511
publishDate 2018-06-01
description Objectives: Hepatitis E virus (HEV) is a single-stranded RNA virus infecting a variety of animals and humans. Little is known of HEV infection among cancer patients in China. This study provides new epidemiological data for the prevalence of HEV co-infection in cancer patients, indicating that HEV infection is common in this group. Methods: A total of 950 cancer patients and 950 control volunteers from Shandong Province, eastern China, were recruited to participate in this investigation. Blood samples from patients and controls were examined for anti-HEV IgG and IgM antibodies using ELISAs. Results: The overall seroprevalence of IgG and IgM antibodies to HEV was significantly higher in cancer patients (247/950, 26.0%) than in controls (123/950, 13.0%) (p < 0.001). In cancer patients, 22.7% of serum samples were anti-HEV IgG-positive, and in control subjects, 11.0% were anti-HEV IgG-positive (p < 0.001). For IgM antibodies, seroprevalence was 4.2% in cancer patients (n = 40) and 2.1% in controls (n = 20) (p = 0.009). The seroprevalence of HEV was higher in cancer patients who had dogs in their home (31.7%) when compared to other cancer patients. The highest seroprevalence of HEV infection was found in leukemia patients (32.3%), followed by liver cancer patients (31.1%); the lowest HEV seroprevalence was detected in patients with gastric cancer (18.9%). Conclusions: This investigation revealed that the seroprevalence of HEV was significantly higher in cancer patients than in controls in eastern China. Therefore, cancer patients are a high-risk population and should be kept away from sources of HEV infection.
topic Hepatitis E virus
Cancer patients
Seroprevalence
Risk factors
China
url http://www.sciencedirect.com/science/article/pii/S1201971218300869
work_keys_str_mv AT mengjiebai seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina
AT nazhou seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina
AT weidong seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina
AT guangxingli seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina
AT weicong seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina
AT xingquanzhu seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina
_version_ 1725856910202109952